Histologic coagulative tumor necrosis as a prognostic indicator of renal cell carcinoma aggressiveness
β Scribed by Shomik Sengupta; Christine M. Lohse; Bradley C. Leibovich; Igor Frank; R. Houston Thompson; W. Scott Webster; Horst Zincke; Michael L. Blute; John C. Cheville; Eugene D. Kwon
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 459 KB
- Volume
- 104
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Background and Objectives: Tumor size is one of the independent factors affecting prognosis of patients with soft tissue sarcoma (STS). We evaluated the significance of tumor size in combination with tumor depth in each histologic grade. Methods: A total of 162 adult patients with localized STS in t
Background. Nuclear deoxyribonucleic acid (DNA) content is a prognostic factor in several tumors, and decisions regarding treatment have been made using this parameter. Nevertheless, there is no agreement in head and neck cancer. The purpose of the present study was to ascertain whether tumor DNA co
Background. Tumor angiogenesis has been shown to correlate with tumor size, metastatic potential, and prognosis in breast and other cancers. Studies in head and neck cancer have suggested a similar correlation, but results have been inconclusive. This study was performed to determine the correlation
## Abstract ## BACKGROUND. Kiβ67 is a cell proliferation protein associated with aggressive clear cell renal cell carcinoma (ccRCC). A recent report suggests that Kiβ67 may represent a surrogate marker for coagulative tumor necrosis. Thus, the goal was to directly test whether Kiβ67 and necrosis c
## BACKGROUND. In vitro studies have shown an antiproliferative effect of tumor necrosis factor (TNF) against various nonsmall cell lung carcinoma (NSCLC) cell lines. However, clinical trials of combined interleukin-2 and TNF-β£ in patients with advanced NSCLC have demonstrated both conflicting and